CD8A and tuberculosis: These results indicated that BCG-Nanocage immunization could also enhance the ability of CD4+ and CD8+ T cells to produce anti-TB cytokines or cytolytic molecules, further highlighting the potency of BCG-Nanocage to enhance Th1/Th1-like or cytotoxic responses of CD4+ or CD8+ T cells.